References
Original article
Fizazi, K. et al. Rucaparib or physician’s choice in metastatic prostate cancer. N. Engl. J. Med. 388, 719–732 (2023)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stone, L. Rucaparib improves PFS in patients with BRCA1/2-altered mCRPC. Nat Rev Urol 20, 199 (2023). https://doi.org/10.1038/s41585-023-00760-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41585-023-00760-z
- Springer Nature Limited